Yu Lin
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China.
Journal: Lancet (London, England)
Published: September 14, 2024
Influence of age as a continuous variable on survival outcomes and treatment options in patients with upper thoracic esophageal carcinoma.
Journal: Journal of Cancer
Published: February 13, 2023
Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016.
Journal: Journal of the National Cancer Center
Published: August 31, 2022
Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer.
Journal: BMC cancer
Published: April 26, 2021
S-1-Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial.
Journal: Frontiers in oncology
Published: May 11, 2020
Primary tumor regression patterns in esophageal squamous cell cancer treated with definitive chemoradiotherapy and implications for surveillance schemes.
Journal: Cancer management and research
Published: December 17, 2018
Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: May 07, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026